Patent details
EP2305263 Title: Stabilized amorphous forms of imatinib mesylate
Basic Information
- Publication number:
- EP2305263
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP101781169
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Stabilized amorphous forms of imatinib mesylate
- French Title of Invention:
- Formes amorphes stabilisées du mésylate de l'imatinib
- German Title of Invention:
- Stabilisierte amorphe Formen von Imatinib Mesylat
- SPC Number:
Dates
- Filing date:
- 07/06/2007
- Grant date:
- 19/09/2012
- EP Publication Date:
- 19/09/2012
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 06/04/2011
- EP B1 Publication Date:
- 19/09/2012
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 07/06/2016
- Expiration date:
- 07/06/2027
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 07/06/2007
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
1
- Name:
- Kalb Oskar
- Address:
- Switzerland (CH)
2
- Name:
- Goncalves Elisabete
- Address:
- Switzerland (CH)
3
- Name:
- Mutz Michael
- Address:
- Germany (DE)
4
- Name:
- Wirth Wolfgang
- Address:
- Switzerland (CH)
Priority
- Priority Number:
- 07109816
- Priority Date:
- 07/06/2007
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- Main IPC Class:
- A61K 31/506;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 26/05/2015
- Last Annual Fee Paid Number:
- 9
- Last Annual Fee Paid Amount:
- 115 Euro
- Payer:
- MARKS & CLERK LLP
| Filing date | Document type | Number of pages |
|---|